DISCOUNT ZERTIFIKAT - ABBVIE Share Price

Certificat

DE000PN7J7R8

Delayed Deutsche Boerse AG 03:50:32 01/07/2024 pm IST
152.2 EUR +0.20% Intraday chart for DISCOUNT ZERTIFIKAT - ABBVIE
Current month+6.96%
1 month+10.12%
Date Price Change
01/24/01 152.2 +0.20%
28/24/28 151.9 +0.44%
27/24/27 151.2 -1.49%
26/24/26 153.5 +0.84%
25/24/25 152.2 -0.50%

Delayed Quote Deutsche Boerse AG

Last update July 01, 2024 at 03:50 pm IST

More quotes

Static data

Product typeCertificados de Descuento
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN7J7R
ISINDE000PN7J7R8
Date issued 18/08/2023
Maturity 20/12/2024 (173 Days)
Parity 1 : 1
Emission price 127.1
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 153.6
Lowest since issue 119.2
Spread 0.1
Spread %0.07%

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
171.5 USD
Average target price
183.2 USD
Spread / Average Target
+6.83%
Consensus